| 摘要 |
The invention relates to medicaments comprising at least one LHRH antagonist, in particular at least one peptidomimetic LHRH antagonist, for use in treatment or prophylaxis of physiological and/or pathological conditions, wherein the at least one LHRH antagonist is to be administered in an intermediate dose, which does not cause chemical (hormonal) castration. |
